MSD: As MSD puts iconic Januvia and Janumet up for sale, India’s diabetes-drugs market goes into churn

By admin Dec16,2023

A sharp surge in the number of diabetes patients, 77 million and counting, has turned India into a hotspot for deals to buy or sell prestigious medicine brands to treat the chronic disease. In the latest move, the USD60 billion drug giant Merck, known as MSD in India, has decided to put its iconic anti-diabetes brands Januvia and Janumet on the block, several industry executives tell ET Prime. The key patents for the drug granted in India

( Originally published on Dec 01, 2022 )

By admin

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *